Back
NLS Pharmaceutics Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
31
NLSP
NLS Pharmaceutics
Last Price:
3.46
Seasonality Move:
22.75%
Buy
63
CRSP
CRISPR Therapeutics AG
Last Price:
49.84
Seasonality Move:
18.54%
Sell
31
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $3.90. The Score for NLSP is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
CRISPR Therapeutics AG (CRSP)
is a Buy
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $50.73. The Score for CRSP is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- CRSP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $3.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $50.73
The current trend is moderately bullish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
NLSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 40.14 | Sell |
| Chaikin Money Flow: | 48222 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.9 - 4.84) | Sell |
| Bollinger Bands (100): | (4.66 - 7.84) | Sell |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.28 | Buy |
| Relative Strength Index (14 RSI): | 53.94 | Buy |
| Chaikin Money Flow: | -1909202 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.47 - 51.05) | Buy |
| Bollinger Bands (100): | (45.96 - 54.62) | Buy |
NLSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.01 | Sell |
| 20-day SMA: | 4.3 | Sell |
| 50-day SMA: | 4.83 | Sell |
| 200-day SMA: | 7.91 | Sell |
| 8-day EMA: | 4.01 | Sell |
| 20-day EMA: | 4.25 | Sell |
| 50-day EMA: | 4.91 | Sell |
| 200-day EMA: | 9.74 | Sell |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.44 | Sell |
| 20-day SMA: | 49.41 | Buy |
| 50-day SMA: | 47.65 | Buy |
| 200-day SMA: | 57.85 | Sell |
| 8-day EMA: | 51.25 | Sell |
| 20-day EMA: | 49.77 | Buy |
| 50-day EMA: | 49.05 | Buy |
| 200-day EMA: | 53.76 | Sell |
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.19 per share, and an increase next year of $0.13 per share.
NLS Pharmaceutics Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||